0000950170-24-031815.txt : 20240314
0000950170-24-031815.hdr.sgml : 20240314
20240314203506
ACCESSION NUMBER: 0000950170-24-031815
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240309
FILED AS OF DATE: 20240314
DATE AS OF CHANGE: 20240314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cigler Tessa
CENTRAL INDEX KEY: 0002015142
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35610
FILM NUMBER: 24752176
MAIL ADDRESS:
STREET 1: C/O ATOSSA THERAPEUTICS, INC.
STREET 2: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATOSSA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001488039
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 264753208
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
BUSINESS PHONE: 206.588.0256
MAIL ADDRESS:
STREET 1: 107 SPRING STREET
CITY: SEATTLE
STATE: WA
ZIP: 98104
FORMER COMPANY:
FORMER CONFORMED NAME: ATOSSA GENETICS INC
DATE OF NAME CHANGE: 20100325
4
1
ownership.xml
4
X0508
4
2024-03-09
0001488039
ATOSSA THERAPEUTICS, INC.
ATOS
0002015142
Cigler Tessa
C/O ATOSSA THERAPEUTICS, INC.
107 SPRING STREET
SEATTLE
WA
98104
true
false
false
false
false
Stock Option (right to buy)
1.09
2024-03-09
4
A
false
20834
0.00
A
2034-03-09
Common Stock
20834
20834
D
The options shall vest in four equal quarterly installments following March 9, 2024, subject to the Reporting Person's continued service through each applicable date.
/s/ Heather Rees, as attorney-in-fact for Tessa Cigler
2024-03-14